Novo Nordisk Confirms Cyberattack and Clarifies Scope of Stolen Data

Novo Nordisk confirmed a cyberattack involving unauthorized access to a limited number of internal IT systems and the copying of clinical trial data. Some personal data was stolen; no attacker or group has claimed responsibility.